Intra-observer agreements in multidisciplinary team assessments of pancreatic cancer patients

J. Kirkegard*, M. Al-Saiddi, S.O. Bratlie, M. Coolsen, R.J. de Haas, M. den Dulk, C. Fristrup, O.J. Greve, E. Harrison, G. Koutouzi, R.L. Miclea, M.B. Mortensen, M.W. Nijkamp, J. Persson, F.P. Robertson, J.J.G. Slangen, J.A. Soreide, S.J. Wigmore, F.V. Mortensen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1402-1408
Number of pages7
JournalJournal of Surgical Oncology
Volume124
Issue number8
Early online date7 Sep 2021
DOIs
Publication statusPublished - Dec 2021

Keywords

  • neoadjuvant chemotherapy
  • pancreatic cancer
  • resectability
  • treatment allocation
  • variation
  • TUMOR BOARD
  • MANAGEMENT

Cite this